Optimization of the MACE endpoint composition to increase power in studies of lipid-lowering therapies—a model-based meta-analysis

AimsTo develop a model-informed methodology for the optimization of the Major Adverse Cardiac Events (MACE) composite endpoint, based on a model-based meta-analysis across anti-hypercholesterolemia trials of statin and anti-PCSK9 drugs.Methods and resultsMixed-effects meta-regression modeling of sta...

Cijeli opis

Bibliografski detalji

Glavni autori:	Alina Volkova, Boris Shulgin, Gabriel Helmlinger, Kirill Peskov, Victor Sokolov
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2024-01-01
Serija:	Frontiers in Cardiovascular Medicine
Teme:	MACE cardiovascular disease dyslipidemia biomarkers lipid-lowering medication model-based meta-analysis sample size
Online pristup:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1242845/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!